• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻成年人中的胰腺癌——一种不断演变的疾病?

Pancreatic cancer in young adults - an evolving entity?

作者信息

Li Yifan, Zhang Xiaojuan

机构信息

Hepatobiliary, Pancreatic and Gastrointestinal Surgery, Shanxi Province Carcinoma Hospital, Shanxi Hospital Affiliated to Carcinoma Hospital, Chinese Academy of Medical Sciences, Carcinoma Hospital Affiliated to Shanxi Medical University Taiyuan 030013, Shanxi, PR China.

Radiology Department, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University Taiyuan 030013, Shanxi, PR China.

出版信息

Am J Cancer Res. 2023 Jul 15;13(7):2763-2772. eCollection 2023.

PMID:37559978
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10408474/
Abstract

The incidence of early-onset pancreatic cancer (EOPC) among young population (<50 years) is rising in the last decade, with gender, medical overtreatment, and genetic factors as the risk factors in EOPC. Nevertheless, the role of genetic factors in the development of EOPC needs further exploration since the studies were carried out with small sample size and ambiguous evidence. Notable, the high incidence of pathogenic germline variant (PGV) appears to be involved in EOPC. Compared with average-age-onset pancreatic cancer (AOPC), EOPC patients display a distinctive genomic feature on several well-known tumor suppressor and oncogenic genes including, including SMAD4, RAS wild wild-type, CDKN2A BRCA1, BRCA2 and FOXC2, which is different from the findings of studies with AOPC and LOPC, suggesting the dynamic evolving entity of EOPC. In addition, the potential gender-related incidence found in several countries also suggests the involvement of genetic or socioenvironmental factors in the development of AOPC. Therefore, further prospective epidemiological and molecular studies are warranted to elucidate the shifting epidemiology of this disease and, most importantly, to better exploit the opportunities for the early diagnosis of the disease.

摘要

在过去十年中,年轻人群(<50岁)中早发性胰腺癌(EOPC)的发病率呈上升趋势,性别、医疗过度治疗和遗传因素是EOPC的危险因素。然而,由于相关研究样本量小且证据不明确,遗传因素在EOPC发生发展中的作用仍需进一步探索。值得注意的是,致病性种系变异(PGV)的高发生率似乎与EOPC有关。与平均年龄发病的胰腺癌(AOPC)相比,EOPC患者在几个著名的肿瘤抑制基因和致癌基因上表现出独特的基因组特征,包括SMAD4、RAS野生型、CDKN2A、BRCA1、BRCA2和FOXC2,这与AOPC和晚发性胰腺癌(LOPC)的研究结果不同,提示EOPC是一个动态演变的实体。此外,在几个国家发现的潜在性别相关发病率也表明遗传或社会环境因素参与了AOPC的发生发展。因此,有必要进一步开展前瞻性流行病学和分子研究,以阐明这种疾病不断变化的流行病学特征,最重要的是,更好地利用机会实现疾病的早期诊断。

相似文献

1
Pancreatic cancer in young adults - an evolving entity?年轻成年人中的胰腺癌——一种不断演变的疾病?
Am J Cancer Res. 2023 Jul 15;13(7):2763-2772. eCollection 2023.
2
Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival.早发性胰腺癌:分子机制、治疗和生存的综述。
Oncotarget. 2022 Jun 15;13:828-841. doi: 10.18632/oncotarget.28242. eCollection 2022.
3
Treatment patterns and survival in patients with early-onset pancreatic cancer.早发性胰腺癌患者的治疗模式和生存情况。
Cancer. 2021 Oct 1;127(19):3566-3578. doi: 10.1002/cncr.33664. Epub 2021 Jul 6.
4
Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?深入研究早发性胰腺导管腺癌:年龄因素如何影响?
Clin Cancer Res. 2021 Jan 1;27(1):246-254. doi: 10.1158/1078-0432.CCR-20-1042. Epub 2020 Sep 21.
5
The Association between Early-Onset Pancreatic Ductal Adenocarcinoma and Patients Survival: A Systematic Review and Meta-Analysis.早发性胰腺导管腺癌与患者生存率之间的关联:一项系统评价和荟萃分析。
F1000Res. 2024 Aug 28;13:976. doi: 10.12688/f1000research.153743.1. eCollection 2024.
6
Early-onset pancreatic cancer: a population-based study using the SEER registry.早发性胰腺癌:基于人群的 SEER 登记研究。
Langenbecks Arch Surg. 2019 Aug;404(5):565-571. doi: 10.1007/s00423-019-01810-0. Epub 2019 Aug 3.
7
Clinical and genomic characterisation of early-onset pancreatic cancer.早发性胰腺癌的临床和基因组特征。
Eur J Cancer. 2023 Nov;194:113338. doi: 10.1016/j.ejca.2023.113338. Epub 2023 Sep 9.
8
Early-onset pancreatic cancer: A national cancer registry study from the Czech Republic and review of the literature.早发性胰腺癌:一项来自捷克共和国的国家癌症登记研究及文献综述
J Hepatobiliary Pancreat Sci. 2023 Dec;30(12):1324-1333. doi: 10.1002/jhbp.1359. Epub 2023 Sep 26.
9
Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data.早期胰腺癌——利用真实世界数据探索当代治疗方法和结果。
Br J Cancer. 2024 May;130(9):1477-1484. doi: 10.1038/s41416-024-02619-5. Epub 2024 Mar 6.
10
Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications.中国胰腺癌患者的致病基因组改变及其治疗意义。
Cancer Med. 2023 May;12(10):11672-11685. doi: 10.1002/cam4.5871. Epub 2023 Mar 31.

引用本文的文献

1
Temporal trends in cross-country inequalities of early-onset pancreatic cancer: a comprehensive analysis for the global burden of disease study 2021.早发性胰腺癌跨国不平等的时间趋势:2021年全球疾病负担研究的综合分析
Sci Rep. 2025 Apr 28;15(1):14835. doi: 10.1038/s41598-025-93892-8.
2
Potential of Proliferative Markers in Pancreatic Cancer Management: A Systematic Review.增殖标志物在胰腺癌治疗中的潜力:一项系统评价。
Health Sci Rep. 2025 Mar 5;8(3):e70412. doi: 10.1002/hsr2.70412. eCollection 2025 Mar.
3
The burden and temporal trend of early onset pancreatic cancer based on the GBD 2021.基于全球疾病负担研究(GBD)2021的早发性胰腺癌负担及时间趋势
NPJ Precis Oncol. 2025 Jan 30;9(1):32. doi: 10.1038/s41698-025-00820-0.
4
Early onset pancreatic cancer: A review.早发性胰腺癌:综述
Transl Oncol. 2025 Feb;52:102239. doi: 10.1016/j.tranon.2024.102239. Epub 2024 Dec 12.
5
Proteomic biomarkers profiling in Pakistani pancreatic ductal adenocarcinoma population: a retrospective cohort study.巴基斯坦胰腺导管腺癌人群的蛋白质组学生物标志物分析:一项回顾性队列研究。
Biomark Med. 2024;18(21-22):969-982. doi: 10.1080/17520363.2024.2416888. Epub 2024 Nov 7.
6
Epigenetic regulation of the tumor microenvironment: A leading force driving pancreatic cancer.肿瘤微环境的表观遗传调控:推动胰腺癌发展的主导力量。
Pancreatology. 2024 Sep;24(6):878-886. doi: 10.1016/j.pan.2024.07.005. Epub 2024 Jul 15.
7
Early-onset gastrointestinal cancer: An epidemiological reality with great significance and implications.早发性胃肠道癌:一个具有重大意义和影响的流行病学现实。
World J Gastrointest Oncol. 2024 Mar 15;16(3):583-597. doi: 10.4251/wjgo.v16.i3.583.

本文引用的文献

1
Adagrasib in Advanced Solid Tumors Harboring a Mutation.在携带突变的晚期实体瘤中应用阿达格拉西布
J Clin Oncol. 2023 Sep 1;41(25):4097-4106. doi: 10.1200/JCO.23.00434. Epub 2023 Apr 26.
2
Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas.p16表达缺失是恶性脑膜瘤中CDKN2A纯合缺失的敏感标志物。
Acta Neuropathol. 2023 Apr;145(4):497-500. doi: 10.1007/s00401-023-02544-6. Epub 2023 Feb 1.
3
Sotorasib in p.G12C-Mutated Advanced Pancreatic Cancer.索托拉西布治疗 p.G12C 突变型晚期胰腺癌。
N Engl J Med. 2023 Jan 5;388(1):33-43. doi: 10.1056/NEJMoa2208470. Epub 2022 Dec 21.
4
Early-onset pancreatic cancer: Clinical characteristics and survival outcomes.早发性胰腺癌:临床特征与生存结局
Pancreatology. 2022 May;22(4):507-515. doi: 10.1016/j.pan.2022.04.003. Epub 2022 Apr 7.
5
Trends in the Incidence and Treatment of Early-Onset Pancreatic Cancer.早发性胰腺癌的发病率及治疗趋势
Cancers (Basel). 2022 Jan 7;14(2):283. doi: 10.3390/cancers14020283.
6
Expanding the Reach of Precision Oncology by Drugging All KRAS Mutants.通过靶向所有 KRAS 突变体来拓展精准肿瘤学的应用范围。
Cancer Discov. 2022 Apr 1;12(4):924-937. doi: 10.1158/2159-8290.CD-21-1331.
7
Incidence of Pancreatic Cancer by Age and Sex in the US, 2000-2018.美国 2000-2018 年按年龄和性别划分的胰腺癌发病率。
JAMA. 2021 Nov 23;326(20):2075-2077. doi: 10.1001/jama.2021.18859.
8
Treatment patterns and survival in patients with early-onset pancreatic cancer.早发性胰腺癌患者的治疗模式和生存情况。
Cancer. 2021 Oct 1;127(19):3566-3578. doi: 10.1002/cncr.33664. Epub 2021 Jul 6.
9
Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in , , or .铂敏感的晚期胰腺癌且存在种系或体细胞致病变体的患者中,维持使用鲁卡帕尼的II期研究。 (注:原文中“in , , or .”部分内容缺失,以上是按完整句子结构翻译的大致内容)
J Clin Oncol. 2021 Aug 1;39(22):2497-2505. doi: 10.1200/JCO.21.00003. Epub 2021 May 10.
10
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.胰腺导管腺癌临床实践指南(第 2.2021 版),NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2021 Apr 1;19(4):439-457. doi: 10.6004/jnccn.2021.0017.